Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2016 - 2025)
Edwards Lifesciences has reported Change in Acquisitions & Divestments over the past 16 years, most recently at -$2.0 billion for Q4 2025.
- Quarterly results put Change in Acquisitions & Divestments at -$2.0 billion for Q4 2025, down 884.41% from a year ago — trailing twelve months through Dec 2025 was $62.1 million (down 92.24% YoY), and the annual figure for FY2025 was $62.1 million, down 92.24%.
- Change in Acquisitions & Divestments for Q4 2025 was -$2.0 billion at Edwards Lifesciences, down from $669.7 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for EW hit a ceiling of $1.4 billion in Q2 2025 and a floor of -$2.0 billion in Q4 2025.
- Median Change in Acquisitions & Divestments over the past 5 years was $95.0 million (2022), compared with a mean of $107.2 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 12536.67% in 2024 and later tumbled 884.41% in 2025.
- Edwards Lifesciences' Change in Acquisitions & Divestments stood at $128.0 million in 2021, then fell by 25.78% to $95.0 million in 2022, then soared by 454.11% to $526.4 million in 2023, then plummeted by 50.42% to $261.0 million in 2024, then tumbled by 884.41% to -$2.0 billion in 2025.
- The last three reported values for Change in Acquisitions & Divestments were -$2.0 billion (Q4 2025), $669.7 million (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.